-
Health Advisory: Pertussis increase in Washington
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Health Alert, Immunization, Immunizations, Infection Control, News and Alerts, News and Update, Pertussis, Provider ResourcesACTIONS REQUESTED BE AWARE of an increase in pertussis has been reported in some areas of Washington state and that patients with a history of receiving pertussis vaccine can still get pertussis. Persons at high risk for pertussis: CONSIDER pertussis infection in the following situations: IF YOU SUSPECT PERTUSSIS IN A PATIENT: Diagnosing pertussis can be difficult, particularly during the early…
-
Health Advisory: Increase in Extensively Drug-Resistant Shigellosis
Advisory or Update, Health Advisory, Health Alert, Infection Control, Notifiable Conditions, Provider ResourcesActions requested Background Centers for Disease Control and Prevention (CDC) is monitoring an increase in XDR Shigella infections (shigellosis) reported through national surveillance systems. In 2022, about 5% of Shigella infections reported to CDC were XDR strains, compared with 0% in 2015. CDC defines XDR Shigella bacteria as strains resistant to all commonly recommended antibiotics: azithromycin,…
-
Kitsap Respiratory Illness Report: February 26 – March 4
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Influenza, Influenza Update, Novel Coronavirus, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 9 of the Kitsap Respiratory Illness Report: 02.26.23-03.04.23. Summary: Local influenza activity is currently low, with 2 positive influenza tests in the past week (1,693 cumulative (17.0% of total tested) since 10/2/2022). RSV activity is currently low, with 0 positive RSV tests in the past week (490 since the start of the…
-
Health Advisory: Updates on Buprenorphine and Controlled Substances Prescribing, Overdose Data, Naloxone, and Xylazine
Actions requested Contacting the health district
-
Kitsap Respiratory Illness Report: February 19 – February 25
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Influenza, Influenza Update, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 7 of the Kitsap Respiratory Illness Report: 02.19.23-02.25.23. Summary: Local influenza activity is currently low, with 2 positive influenza tests in the past week (1,691 cumulative (17.6% of total tested) since 10/2/2022). RSV activity is currently low, with 2 positive RSV tests in the past week (490 since the start of…
-
Health Advisory: Increase COVID-19 Treatment Access, Prescribing and Uptake
Advisory or Update, COVID-19, Health Advisory, Health Alert, Immunization, Infection Control, News and Alerts, News and Update, Novel Coronavirus, Provider ResourcesActions requested For questions, please contact our Immunizations/COVID Program at 360-728-2007. Background While COVID-19 treatment is shown to reduce hospitalization, it is under-used for high-risk patients with acute COVID-19. High-risk patients include: COVID-19 continues to cause between 2,000 and 4,000 deaths each week in the United States (see CDC’s Trends in Number of COVID-19 Cases…
-
Kitsap Respiratory Illness Report: February 12 – February 18
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Influenza, Influenza Update, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 7 of the Kitsap Respiratory Illness Report: 02.12.23-02.18.23. Summary: Local influenza activity is currently low, with 9 positive influenza tests in the past week (1,689 cumulative (18.2% of total tested) since 10/2/2022). RSV activity is currently low, with 4 positive RSV tests in the past week (488 since the start of…
-
Kitsap Respiratory Illness Report: February 5 – February 11
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 6 of the Kitsap Respiratory Illness Report: 02.05.23-02.11.23. Summary: Local influenza activity is currently low, with 5 positive influenza tests in the past week (1,680 cumulative (18.9% of total tested) since 10/2/2022). RSV activity is currently low, with 2 positive RSV tests in the past week (484 since the start of…
-
Kitsap Respiratory Illness Report: January 29 – February 4
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Respiratory Illness ReportClick here to access week 4 of the Kitsap Respiratory Illness Report: 01.29.23-02.04.23. Summary: Local influenza activity is currently low, with 4 positive influenza tests in the past week (1,675 cumulative (19.7% of total tested) since 10/2/2022). RSV activity is currently elevated, with 6 positive RSV tests in the past week (482 since the start of…
-
Kitsap Respiratory Illness Report: January 22 – January 28
Advisory or Update, Communicable Disease Data Report, Influenza, Influenza Update, Respiratory Illness ReportClick here to access week 4 of the Kitsap Respiratory Illness Report: 01.22.2023 – 01.28.2023. Summary: Local influenza activity is currently low, with 2 positive influenza tests in the past week (1,671 cumulative (20.6% of total tested) since 10/2/2022). RSV activity is currently elevated, with 5 positive RSV tests in the past week (476 since the…
-
Evusheld no longer authorized for COVID-19 prevention
Advisory or Update, COVID-19, Infection Control, News and Alerts, News and Update, Novel Coronavirus, Prevention, Provider ResourcesOn January 26, 2023, the Food and Drug Administration (FDA) announced that Evusheld (tixagevimab co-packaged with cilgavimab) is not currently authorized for use in the U.S. Facilities and providers should continue to store Evusheld in the event that variants susceptible to Evusheld become more prevalent. Evusheld Effectiveness Evusheld is unlikely to be active against SARS-CoV-2 variants projected…
-
Health Advisory: EzriCare Artificial Tears linked to antibiotic-resistant infections
Advisory or Update, Emerging Diseases and Conditions, Health Advisory, Health Alert, Infection Control, News and Alerts, News and Update, Provider ResourcesActions Requested Background The Centers for Disease Control and Prevention (CDC) is investigating a multistate cluster of Verona Integron‐mediated Metallo‐β‐lactamase (VIM)‐ and Guiana‐Extended Spectrum‐β‐Lactamase (GES)‐ producing carbapenem‐resistant Pseudomonas aeruginosa (VIM‐GES‐CRPA) associated with multiple different infection types, including eye infections. Recent epidemiology and laboratory evidence link these infections to use of EzriCare Artificial Tears. These over-the-counter…
-
Health Advisory: King County measles case traveled through SeaTac airport
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Health Alert, Immunization, Immunizations, Measles, News and Alerts, News and Update, Notifiable Conditions, Provider Resources, Travel, VaccineActions Requested Background Current situation Seattle King County Public Health is investigating a local case of measles in an adult who was exposed while overseas. The case was at SeaTac airport and Providence Swedish First Hill Emergency Department during their infectious period before receiving the diagnosis of measles. The case did not wear a face…